Provided by Tiger Trade Technology Pte. Ltd.

Allogene Therapeutics Inc.

2.17
+0.14006.90%
Pre-market: 2.15-0.0200-0.92%05:33 EDT
Volume:6.16M
Turnover:13.34M
Market Cap:748.65M
PE:-3.33
High:2.21
Open:2.05
Low:2.05
Close:2.03
52wk High:4.46
52wk Low:1.04
Shares:345.00M
Float Shares:267.00M
Volume Ratio:1.24
T/O Rate:2.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6510
EPS(LYR):-0.8652
ROE:-42.39%
ROA:-22.08%
PB:1.72
PE(LYR):-2.51

Loading ...

Mar 14, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 14, 2024

Major Issues Report

Form 8-K - Current report
Mar 14, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
Feb 23, 2024

Correspondence

Form CORRESP - Correspondence
Feb 16, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 31, 2024

Major Issues Report

Form 8-K - Current report
Jan 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2024

Major Issues Report

Form 8-K - Current report
Dec 20, 2023

Major Issues Report

Form 8-K - Current report
Dec 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2023

Correspondence

Form CORRESP - Correspondence
Nov 03, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2023

Major Issues Report

Form 8-K - Current report
Oct 26, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Oct 18, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Oct 16, 2023

Major Issues Report

Form 8-K - Current report